The proposed Lawful Hemp Protection Act (LHPA), introduced by Kentucky Representative Andy Barr, aims to amend the 2018 Farm Bill and significantly reshape US industrial hemp policy. Surfacing earlier this month, the draft legislation primarily addresses the contentious issue of cannabinoid regulation, seeking to curb the proliferation of synthetic intoxicating hemp products while simultaneously establishing a clear legal pathway for “wellness” CBD products. However, the bill has sparked debate among industry stakeholders regarding its focus, with many questioning its commitment to fostering broader markets for industrial hemp applications such as fiber, food, and feed, as reported by HempToday.net.
Reforming Cannabinoid Markets and Industrial Hemp Policy
The LHPA’s initial draft proposes critical changes intended to address the “intoxicating hemp” market that has emerged following the 2018 Farm Bill. This grey market, characterized by products often marketed to youth, has drawn significant criticism and regulatory concern. The bill seeks to:
- Shut down the economy built around synthetic intoxicants derived from hemp.
- Create a defined legal framework for non-intoxicating CBD products, ensuring their continued availability for wellness applications.
While these provisions are largely seen as a necessary step to restore credibility to the hemp sector, the focus on cannabinoids has, as previously reported by Hemp Gazette in articles such as “Redefining Hemp In The USA: Further Clarification,” often overshadowed the potential for true industrial hemp development. The 2018 Farm Bill, which legalised hemp, was initially envisioned to unlock vast agricultural and manufacturing opportunities for fiber, grain, and sustainable building materials. Instead, it inadvertently facilitated a grey-market intoxicant economy, diverting attention and resources from the plant’s full industrial potential.
Stakeholder Divisions on Hemp’s Future
The debate surrounding Representative Barr’s bill highlights the divergent interests within the broader cannabis industry. Several key groups have weighed in:
- HIFA: This group advocates for the legalization, normalisation, and regulation of the illicit intoxicant sector, seeking broad commercial latitude for these products.
- Ad Hoc Group (including U.S. Hemp Roundtable and National Industrial Hemp Council of America – NIHC): These signatories have thanked Barr for the bill but urged the inclusion of language that would permit intoxicating hemp beverages, provided they are regulated similarly to alcohol.
- ATACH: Representing licensed marijuana operators, ATACH seeks the complete elimination of intoxicating hemp products, arguing they undercut state-regulated cannabis markets. Their position underscores the competitive pressures facing established cannabis businesses.
This ongoing focus on cannabinoid-centric discussions has, according to industry observers, left the industrial side of hemp “policy-orphaned” through successive legislative cycles. Despite the plant’s potential for high-value food products and hundreds of cutting-edge applications in major global industries, Washington has made limited progress in establishing pathways to fully realise these benefits.
Charting a Course for True Industrial Hemp Growth
While the LHPA’s intent to regulate synthetic intoxicants and protect legitimate CBD trade is commendable, its narrow scope raises questions about the future trajectory of US industrial hemp policy. Critics argue that if future legislation remains confined to managing existing CBD and hemp-derived THC markets, it risks repeating past oversights and failing to capitalise on hemp’s broader economic promise.
The long-term future of hemp, particularly for investors and operators seeking sustainable growth, lies beyond the “gas-station cooler” market. There is a pressing need for legislative frameworks that actively support farmers, processors, and manufacturers engaged in truly industrial hemp production. This includes:
- Incentivising investment in hemp processing infrastructure for fiber and grain.
- Developing clear regulatory pathways for hemp-derived food and feed products.
- Promoting research and development into advanced material applications for hemp stalk.
Moving forward, a comprehensive approach to industrial hemp policy is required—one that balances necessary cannabinoid regulation with robust support for the plant’s diverse agricultural and manufacturing potential, ensuring that the next chapter of US hemp law fosters genuine, long-term industry growth.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
